Tiansheng Pharmaceutical Group Co (002872.SZ) Stock Price

Tiansheng Pharmaceutical Group Co Price

CLOSED
6.12
​
Market closed

Revenue at Tiansheng Pharmaceutical Group Co has contracted by 5.0% per year over the past 13 years to 514.09 M CNY. Earnings per share have declined at 5.5% per year over the last 6 years. Tiansheng Pharmaceutical Group Co's net margin stands at -10.8%, down from -9.2% several years earlier. Tiansheng Pharmaceutical Group Co currently offers a dividend yield of about 2.57%. The payout ratio is around 64% of earnings.

Tiansheng Pharmaceutical Group Co stock price

Access this data via the Eulerpool API

Tiansheng Pharmaceutical Group Co business model & stock analysis

Tiansheng Pharmaceutical Group Co., Ltd. is a holding company that manufactures pharmaceutical products. The company is headquartered in Chongqing, Chongqing and currently employs 1,330 full-time employees. The company went IPO on 2017-05-19. The firm's main products include pediatric lung cough particles, erythromycin enteric-coated capsules, silver ginseng Tongluo capsules, Salvia granules, Shugan Yi spleen granules, compound Ganoderma lucidum granules, Xiangdan injection, Injection, Qi and Diabetes tablets, liver capsule, Ling Jing capsule, lungs of nuclear paste, Shen Qi Yi lung pill, among others. The firm mainly distributes its products within domestic market.

Frequently asked questions about Tiansheng Pharmaceutical Group Co

Converted at the current exchange rate, the Tiansheng Pharmaceutical Group Co share trades at 0.81 EUR (6.12 CNY).

The revenue cannot currently be calculated for Tiansheng Pharmaceutical Group Co.

The profit cannot currently be calculated for Tiansheng Pharmaceutical Group Co.

The P/E ratio cannot be calculated for Tiansheng Pharmaceutical Group Co at the moment.

The P/S cannot be calculated for Tiansheng Pharmaceutical Group Co currently.

The Eulerpool Quality Score for Tiansheng Pharmaceutical Group Co is 1/10.

The ISIN of Tiansheng Pharmaceutical Group Co is CNE100002QC3. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Tiansheng Pharmaceutical Group Co is 002872.SZ. The ticker symbol is used to trade Tiansheng Pharmaceutical Group Co shares on the stock exchange.

Fair ValueTerminal
6.36 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
386,532.11 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website tszy.com.cn
Country
Currency
CNY
Initial public offering
May 19, 2017
ISIN
CNE100002QC3
Cusip
Y8817J107
Market capitalization
1.95 B CNYSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
1.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-2.65 %
Last updated Oct 9, 2026, 3:39 PM

Tiansheng Pharmaceutical Group Co Peer Group

Tiansheng Pharmaceutical Group Co FIGI

002872:CH · BBG002NC5XH7002872:CS · BBG009J2ZJM1